tiprankstipranks
Zoetis (GB:0M3Q)
LSE:0M3Q
UK Market

Zoetis Stock Analysis & Ratings

GB:0M3Q Stock Chart & Stats

Day’s Range$165.41 - $167.3622
52-Week Range$0.00 - $0.00
Previous Close$162.46
Volume840.00
Average Volume (3M)4.37K
Market Cap$78.06B
P/E Ratio38.1
Beta0.45
Next EarningsAug 04, 2022
Dividend Yield1.15 (0.69%)
Smart Score5
EPS (TTM)4.36


Financials

Yearly

P/E Ratio Range

The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.

---

GB:0M3Q FAQ

What was Zoetis’s price range in the past 12 months?
Zoetis lowest stock price was $0.00 and its highest was $0.00 in the past 12 months.
    What is Zoetis’s market cap?
    Zoetis’s market cap is $78.06B.
      What is Zoetis’s price target?
      The average price target for Zoetis is $231.40. This is based on 5 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
      The highest analyst price target is $254.00 ,the lowest forecast is $208.00. The average price target represents 39.52% Increase from the current price of $165.86.
        What do analysts say about Zoetis?
        Zoetis’s analyst rating consensus is a ‘Strong Buy. This is based on the ratings of 5 Wall Streets Analysts.
          When is Zoetis’s upcoming earnings report date?
          Zoetis’s upcoming earnings report date is Aug 04, 2022 which is in 80 days.
            How were Zoetis’s earnings last quarter?
            Zoetis released its earnings results on May 05, 2022. The company reported $1.32 earnings per share for the quarter, beating the consensus estimate of $1.23 by $0.09.
              Is Zoetis overvalued?
              According to Wall Street analysts Zoetis’s price is currently Undervalued.
                Does Zoetis pay dividends?
                Zoetis pays a Quarterly dividend of $0.32 which represents an annual dividend yield of 0.69%. Zoetis’s last Quarterly dividend payment was on Jun 01, 2022. Zoetis’s upcoming ex-dividend date is Apr 20, 2022
                  What is Zoetis’s EPS estimate?
                  Zoetis’s EPS estimate for its next earnings report is not yet available.
                  How many shares outstanding does Zoetis have?
                  Zoetis has 470,630,000 shares outstanding.
                    What happened to Zoetis’s price movement after its last earnings report?
                    Zoetis reported an EPS of $1.32 in its last earnings report, beating expectations of $1.23. Following the earnings report the stock price went up 0.137%.
                      Which hedge fund is a major shareholder of Zoetis?
                      Among the largest hedge funds holding Zoetis’s share is Sands Capital Management LLC. It holds Zoetis’s shares valued at 557M.

                        ---

                        Zoetis Stock Analysis

                        The Zoetis stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                        Learn more about TipRanks Smart Score

                        Company Description

                        Zoetis

                        Founded in 1952, New Jersey-based Zoetis, Inc. is the world's largest manufacturer of medicine and vaccinations for pets and livestock in the United States and internationally. Its products are complemented by diagnostic products, genetic tests, bio devices and services.

                        ---
                        Similar Stocks
                        Company
                        Price & Change
                        Follow
                        Idexx Laboratories
                        Phibro Animal Health
                        Immucell
                        Heska
                        Sanofi-Aventis Sa

                        Popular Stocks

                        ---
                        What's Included in PREMIUM?
                        Make informed decisions based on Top Analysts' activity
                        Know what industry insiders are buying
                        Get actionable alerts from top Wall Street Analysts
                        Find out before anyone else which stock is going to shoot up
                        Get powerful stock screeners & detailed portfolio analysis